Novartis Czech Republic - Cost of Financing

Created with Highcharts 6.0.4%20012002200320042005200620072008200920102011201220132014201520162017-200-150-100-50050100

Novartis Czech Republic`s Cost of Financing reached 15.6 % in 2017. This is 72.09999999999999 % less than in the previous year.

$1.99

Buy Cost of Financing data for Novartis Czech Republic.

$19.99

Buy all data for Novartis Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
CompanyUnit
Amgen Czech Republic %
Bayer Czech Republic %
GlaxoSmithKline Czech Republic %
Merck Czech Republic %
Novartis Czech Republic %
Pfizer Czech Republic %
Roche Czech Republic %
Sanofi-Aventis Czech Republic %
Walmark %
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
... ... ... ... ... ... ... ... ... ... ... ... 1,890 11.3 0.592   ...
... ... ... ... ... ... ...     ... ... ... 11.0 6.28 1.76    
... ... ...               1.64 1.09 1.94 1.42 ... ... ...
... ...                 4.81 8.10 4.56 7.78 68.8 ... ...
                    2.97 10.8 36.9 17.3 12.1    
... ... ...             ... 4.09 0.877 ... ... ... ...  
... ... ...               0.316 -2.24 0.681 0.272 0.136   ...
... ... ... ...             1.59 1.50 0.956 1.24 0.511    
... ... ...               6.80 7.39 4.30 5.04 34.6